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Telomeres, the termini of linear chromosomes, are
exceptional in that they are DNA ends that do not nor-
mally trigger a DNA-damage response (DDR) and are
compatible with normal cellular proliferation. Mamma-
lian telomeres are nevertheless a physiological sub-
strate of the DDR apparatus, as shown by the fact
that the inactivation of genes encoding certain DDR
factors results in telomere dysfunction [1–3]. How-
ever, how DDR factors are integrated with telomere
physiology, including telomere length regulation by
the specialized reverse transcriptase telomerase, is
still largely unclear. Here we report that the mamma-
lian Rad9/Rad1/Hus1 (911) checkpoint complex, which
localizes to sites of genome damage and promotes
DDR signaling [4], is an integral component of the
telomere in human and mouse cells. By the use of
quantitative telomere-length measurements, we dem-
onstrate severe telomeric shortening in both Hus1-de-
ficient mouse embryonic fibroblasts and thymocytes
from conditional Hus1-knockout mice. We also show
that 911 is found in association with catalytically com-
petent telomerase in cell lysates and is a positive reg-
ulator of its DNA polymerase activity. These findings
identify an unanticipated function for the 911 check-
point complex at telomeres in mammals and provide
a mechanistic link between the activity of DNA-dam-
age-checkpoint proteins and the telomere-mainte-
nance machinery.
*Correspondence: rsw26@cornell.edu (R.S.W.); fabrizio.dadda@
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5 These authors contributed equally to this work.Results and Discussion
911 Is a Novel Component
of the Mammalian Telomere
To test whether components of the 911 complex are as-
sociated with the human telomere, we performed chro-
matin immunoprecipitation (ChIP) assays, a technique
that allows detection of the association of proteins
with chromatin at specific genomic sites [5]. Figure 1A
shows that a panel of antibodies raised against different
portions of the individual subunits of this complex [6, 7]
all immunoprecipitated consistent amounts of telomeric
DNA as determined by dot-blot hybridization, whereas
the corresponding preimmune sera did not. By contrast,
when the same membrane was stripped and hybridized
with an Alu DNA probe, as a measure of nonspecific DNA
binding, no difference was detected between the signal
generated by the immune versus preimmune sera.
Quantification of the percentage of telomeric DNA im-
munoprecipitated and the incremental ratio between
the signal generated by the telomeric and Alu probes
demonstrated that the 911 complex was specifically as-
sociated with telomeric DNA. The association of 911
with telomeres required crosslinking prior to cell har-
vesting (Figure 1A and data not shown), indicating that
this interaction probably occurred in vivo and was not
the consequence of in vitro manipulation. In addition, in-
creasing amounts of antibodies against the 911 compo-
nents brought down increasing amounts of telomeric
DNA, up to the saturation point (Figure S1A in the Sup-
plemental Data available with this article online). An ad-
ditional set of experiments performed with immunopuri-
fied antibodies confirmed the results obtained with
crude sera (Figure S1B). The robustness and specificity
of our approach was validated in two additional ways:
precipitation of telomeric DNA by anti-Hus1 antibodies
was eliminated when the ChIP assays were done with
chromatin extracted from Hus1-deficient cells (Fig-
ure S1C), and antibodies raised against HUS1 and
TRF1, a telomeric DNA binding protein, or CENP-A,
a specific centromeric DNA-associated factor, preferen-
tially immunoprecipitated telomeric DNA or centromeric
DNA, respectively, but not the reciprocal or Alu DNA
sequences (Figure 1B).
Telomeric DNA is generally a relatively poor replica-
tion template, causing DNA replication forks to stall
more frequently at these than at other regions of the ge-
nome [8, 9]. Because the 911 complex has been shown
to respond to DNA damage during S phase [10], we
tested whether the association of 911 with telomeric
DNA was dependent on ongoing DNA replication by car-
rying out a set of ChIP assays with chromatin prepared
from human diploid fibroblasts (HDFs) that were either
proliferating or in a quiescent, noncycling state induced
by contact inhibition (Figure 1C). We observed that 911
also associated with telomeres in nondividing cells, indi-
cating that its association is independent of telomeric-
DNA replication. In addition, we observed that 911
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(A) Chromatin immunoprecipitations were performed in HeLa cells by means of a panel of matched preimmune and immune sera raised against
the individual factors HUS1, RAD9, or RAD1 (numbers in parentheses indicate individual immunized rabbits). DNA was spotted onto a membrane
and sequentially hybridized with telomeric or Alu DNA probes. Values for percent of telomeric DNA immunoprecipated (first two columns) were
calculated by dividing the ChIP signal by the signal for a known amount of input chromatin spotted directly onto the membrane. Values shown in
the third column represent the calculated fold increase of the telomeric DNA signal of the immune over the preimmune sera immunoprecipita-
tions upon normalization with the Alu DNA probe. Values shown in the far right column represent the ratio between values shown in the third
column and those obtained in an identical set of immuoprecipitations with chromatin that was not crosslinked (data not shown).
(B) In HeLa cells, antibodies against HUS1 and TRF1, a telomeric DNA binding protein, or against CENP-A, a centromeric-associated protein,
preferentially immunoprecipitate telomeric or centromeric DNA, respectively.
(C) 911 complex is associated with telomeric DNA independently from DNA replication and proliferation in HDFs. HDFs were synchronized by
contact inhibition and subjected to ChIP as described above. Lack of DNA replication was monitored by BrdU incorporation (data not shown).association with telomeres was also detectable in other
cell types, including transformed and primary cells, as
well as in cells that maintain their telomeres through
ALT (alternative lengthening of telomeres) mechanisms,consistent with a previous report [11] (data not shown).
From these results, we therefore conclude that 911 is
a novel component of human and mouse telomeres in
different cell types.
Mammalian Rad9/Rad1/Hus1 Complex at Telomeres
1553Hus1 Regulates Telomere Length
Deletion of mouse Hus1 results in embryonic lethality,
and Hus1 null fibroblasts grow extremely poorly in cul-
ture [10]. However, inactivation of p21 allows the growth
in culture of Hus1-deficient mouse embryonic fibro-
blasts (MEFs) and thereby permits us to determine the
function of Hus1 in telomere homeostasis. Notably, we
observed that immortalized Hus1D1n/D1np212/2 MEFs,
but not Hus1+/+p212/2 MEFs, progressively accumu-
lated chromosomal aberrations, including chromosome
fusions (Figure S2A). Analysis of 20 metaphases from
two independent Hus1D1n/D1np212/2 MEF cultures re-
vealed an average 0.4 and 0.6 chromosome fusions
per cell, whereas no chromosomal fusions were identi-
fied in matched Hus1+/+p212/2 MEF cultures. Fluores-
cence in situ hybridization (FISH) was performed with
a telomere-specific probe to determine whether the
junction between the fused chromosomes retained telo-
meric sequences. Two out of seven junction sites from
chromosomal fusions identified in Hus1D1n/D1np212/2
MEFs contained telomeric sequences (Figure S2B).
Consistent with previous results from analysis of pri-
maryHus1D1n/D1n MEFs [10], chromatid gaps and breaks
were also much more common in Hus1D1n/D1np212/2
MEFs (0.9 or 0.6 gaps and breaks per cell in two inde-
pendent cultures) than in Hus1+/+p212/2 MEFs (0.25 or
0.19 gaps and breaks per cell).
Telomere fusions can result from telomere shortening.
We therefore tested whether Hus1 inactivation impacts
telomere length regulation by using quantitative fluores-
cence in situ hybridization (qFISH), a technique that de-
tects and quantifies the signal generated by hybridiza-
tion of a fluorescent probe complementary to TTAGGG
telomeric repeats at individual chromosome ends at
the single-cell level [12, 13]. Strikingly, when we exam-
ined telomere length in primary (passage 0) Hus1+/+,
Hus1+/D1n, or Hus1D1n/D1n MEFs (Figure 2A), we ob-
served that Hus1-deficient cells exhibited a dramatic
loss of nearly half of their telomere length (48 kb telo-
mere length in Hus1+/+ cells and 27 kb in Hus1D1n/D1n
cells). HeterozygousHus1+/D1ncells also displayed a sig-
nificant reduction (w7 kb) of telomeric repeats when
compared to wild-type cells, demonstrating a haploin-
sufficiency of Hus1 in telomere length control. Without
exception, Hus1D1n/D1n cells had shorter telomeres
than Hus1+/+ cells, and Hus1+/D1n cells had telomeres
of intermediate length. Further analysis of the distribu-
tion of telomere fluorescence demonstrated that telo-
mere shortening involved the bulk of telomeres rather
than a subset of them. Additional analyses of these pri-
mary cells revealed no end-to-end fusions in 26 Hus1+/+
metaphase spreads and only one in 59 spreads from
heterozygotes, but 5 end-to-end fusions were identified
in 30 Hus1D1n/D1n metaphase spreads. Two of these
lacked telomeric sequences at the junction, while the re-
maining three junctions had an average length of 41 Kb
of telomeric DNA.
To ascertain that the telomere maintenance defect
observed in Hus1-deficient fibroblasts was not exclu-
sive to cultured cells or restricted to a specific genetic
background or technique, we performed additional telo-
mere length measurements on primary thymocytes de-
rived from a conditional Hus1 knockout model in which
mice carrying the conditional Hus1 allele Hus1flox werebred to Lck-cre transgenic mice in order to achieve T
cell-specific inactivation of Hus1 [14]. Southern blot
analyses confirmed the efficient T cell-specific deletion
of Hus1 in this system (Figure S3). Thymocytes from
the same mice were also analyzed by flow-FISH, a tech-
nique that measures the total amount of telomeric DNA
in large numbers of permeabilized intact cells in inter-
phase [15] (Figure 2B). Results from the analysis of
mice from four independent litters demonstrated that
complete Hus1 inactivation was associated with severe
telomere shortening, with an average loss of 45% of to-
tal telomeric signal. We therefore conclude that both
constitutive and inducible inactivation of Hus1 leads to
dramatic telomere shortening that is detectable in differ-
ent tissues by two independent techniques.
Since yeast orthologs of 911 components have been
shown to affect telomere resection [16], we also tested
whether telomere structure was compromised in early-
passage Hus1D1n/D1np212/2 MEFs or in unpassaged
thymocytes derived from the conditional Hus1 knockout
model [14]. However, we found no significant differ-
ences in the presence of the single-strand telomeric
overhang between wild-type and Hus1-deleted cells
(Figure S4A). Furthermore, we found no evidence that
the lack of Hus1 leads to telomere uncapping. Uncap-
ping triggers a DDR at telomeres that can be detected
by ChIP assay with antibodies directed against phos-
phorylated histone H2AX (g-H2AX) or against the con-
sensus phosphorylation site of the ATM and ATR
kinases (pS/TQ) [17–19]. There was no significant
association of these DDR markers with telomeric DNA
inHus1-deficient MEFs (Figure S4B). In a parallel control
experiment performed in human cells, telomere uncap-
ping induced by the expression of a dominant-negative
allele of TRF2 [20] triggered a DDR at the telomere (Fig-
ure S4C). These data suggest that telomeres remained
capped in the absence of Hus1, although we cannot
rule out the possibility that 911 itself may be necessary
for DNA-damage signaling from uncapped telomeres.
We conclude that lack of Hus1 does not lead to detect-
able alterations to telomere structure but does have
a profound effect on telomere length.
911 Interacts with Telomerase and Affects Its Activity
The 911 complex shows structural similarities with
PCNA, a ring-shaped factor that associates with pro-
teins involved in DNA replication and repair [4]. We
therefore looked for evidence of a biochemical interac-
tion between the 911 complex and telomerase, the en-
zyme that mediates telomere replication in mammals
[12]. A Flag-tagged version of the 911 complex was
transiently expressed in cultured cells, and the ability
of anti-Flag antibodies to immunoprecipitate telome-
rase activity was monitored by TRAP assay, a method
that measures the in vitro catalytic activity of telomerase
in cell extracts. Figure 3A (left) shows that an anti-Flag
immunoprecipitation brought down high levels of telo-
merase activity from extracts of cells expressing Flag-
tagged 911. Importantly, the interaction between 911
and telomerase was specific, as a Flag peptide, but not
an unrelated peptide, significantly reduced the amount
of telomerase activity brought down. Furthermore, when
we tested whether endogenous 911 was associated
with active telomerase, we found that affinity-purified
Current Biology
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(A) Results from qFISH analysis of telomere length in primary MEFs obtained from two independent litters generated from heterozygous crosses
are shown. One TFU (telomere fluorescence unit) corresponds to 1 kb of TTAGGG repeats. Results are shown for p-arm telomeres, q-arm telo-
meres, and all ends. Values are expressed as mean 6 standard error. The mean value for each genotype is indicated in bold font. Histograms
describe the frequency distribution of qFISH values for the three different genotypes. The horizontal axis shows the intensity of each signal, and
the vertical axis shows the frequency of telomeres of a given length.
(B) Results from telomere length analysis by flow-FISH of uncultured thymocytes are shown. Values are expressed in thousands of molecules of
equivalent soluble fluorochrome (MESF). Values are reported next to their genotype. Thymocytes from Hus1flox/D1Lck-cre+ (conditional knock-
out), Hus1flox/D1Lck-cre2 (control), Hus1+/floxLck-cre2 (control), and Hus1+/floxLck-cre+ (control) experimental animals were analyzed. The mean
value 6 standard error for conditional Hus1 knockout and control samples is indicated in bold font. The statistical significance of telomere
differences between genotypes is described by the calculated p values.antibodies raised against HUS1, RAD1, or RAD9 consis-
tently immunoprecipitated significant amounts of telo-
merase activity (Figure 3B, top). Preincubation of the
anti-RAD1 antibody with a RAD1 peptide eliminated
the coimmunoprecipitation of telomerase activity, sug-
gesting that the interaction was specific. Additional ex-
periments with crude preimmune and immune sera
raised against the individual subunits of 911 confirmed
the interaction of 911 with telomerase (Figure S5). Im-
portantly, ATR and the p34 and p70 subunits of RPA,
chromatin-associated members of the same DDRsignaling pathway as 911 [21], were not found in associ-
ation with telomerase activity (Figure 3C), an observa-
tion that strongly suggests that the association between
911 and telomerase activity was not merely an indirect
association between two DNA bound factors. Taken to-
gether, these data reveal that 911 is uniquely found in
association with catalytically active telomerase.
We then tested the biological significance of the ob-
served 911-telomerase interaction by studying telome-
rase catalytic activity in cell extracts generated from
Hus1+/+p212/2 and Hus1D1n/D1np212/2 MEFs by TRAP
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(A) FLAG antibody coimmunoprecipitates telomerase activity with 911 from 293T cells transiently transfected with FLAG-tagged Rad9, Rad1,
and Hus1, as detected by TRAP assays. A specific competitor peptide, but not an equal amount of an unrelated one, abolished 911 binding
to the beads as determined by immunoblotting (right) and strongly reduced immunoprecipitated TRAP activity. TRAP assays were performed
on untreated or heat-treated samples. Each lane includes an internal control for PCR amplification. Fold increase relative to activity for beads
alone is shown at the bottom.
(B) Affinity-purified antibodies raised against the individual subunits of the 911 complex immunoprecipitate TRAP activity from HeLa cells. A
RAD1 peptide against which the antibody was raised, but not an equal amount of an unrelated peptide, specifically competes for RAD1 binding
as determined by immunoblotting (bottom) and reduces the amount of immunoprecipitated TRAP activity (top).
(C) Antibodies raised against RPA34, RPA70, and ATR do not coimmunoprecipitate telomerase activity from HeLa cells. Successful immunopre-
cipitation of RPA34, RPA70, and ATR is demonstrated by immunoblotting (bottom).
Current Biology
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(A) Hus1 null cells have reduced telomerase activity compared to Hus1-expressing cells over a range of concentrations. Extracts were prepared
from cells of the indicated genotype and subjected to analysis by TRAP assay.
(B) Expression of a Hus1 cDNA in Hus1-deficient cells rescues telomerase activity defect. Hus1+/+p212/2 and Hus1D1n/D1np212/2 MEFs, stably
expressing GFP or Hus1 from a retroviral vector, were subjected to TRAP analysis.
(C) Expression of short interfering RNAs against HUS1 in human cells reduces telomerase activity. HeLa cells were infected with lentiviruses
encoding GFP or shRNAs against HUS1, and the resulting extracts were subjected to TRAP analysis at the indicated times post selection.
(D) Expression of short interfering RNAs againstATR in human cells does not affect telomerase activity. HeLa cells were transfected with siRNAs
against GFP or ATR, and the resulting extracts were subjected to TRAP analysis. Reduced ATR expression was confirmed by indirect immuno-
fluorescence analysis in which cells were stained with anti-ATR antiserum and DAPI (right).assay. This analysis revealed a reproducible 3- to 5-fold
decrease in telomerase activity in cells lacking Hus1
(Figure 4A). Importantly, the TRAP assays were carried
out within the linear range, and these observations could
be reproduced in multiple cell lines generated from inde-
pendent embryos (data not shown). Hus1 deficiency did
not lead to significant alterations in the expression of
core components of telomerase complex as evidenced
by similar amounts of TERT protein and TERC RNA
in Hus1+/+p212/2 and Hus1D1n/D1np212/2 MEFs
(Figure S6). The telomerase activity defect in
Hus1D1n/D1np212/2 MEFs was specifically due to the
absence of Hus1, as it was rescued by expression of
a Hus1 cDNA (Figure 4B).
We further extended our observations to human cells
by expressing a short hairpin RNA against human HUS1
and monitoring its effect on HUS1 protein accumulation
and telomerase activity (Figure 4C). HUS1 knockdowncaused progressive reduction of the ability of telome-
rase to synthesize telomeric repeats, to the same extent
observed in mouse cells. Likewise, reducing expression
of 911 component RAD9, or the clamp loader RAD17, by
RNA interference also impaired telomerase activity
(Figure S7A). These results were specific, as shown
by the fact that knockdown of ATR, or overexpression
of dominant-negative (kinase-dead) ATR, did not signif-
icantly affect TRAP activity (Figure 4D; also Figure S7B).
We therefore conclude that 911 is a positive regulator of
in vitro telomerase activity.
In summary, these results show that the 911 complex
is a novel constitutive component of the mammalian
telomere. One potential mechanism that could lead to
the recruitment of 911 to mammalian telomeres is via
RPA, because RPA-coated ssDNA at sites of DNA dam-
age promotes loading of 911 by a Rad17-containing
clamp-loading complex [22, 23]. However, although
Mammalian Rad9/Rad1/Hus1 Complex at Telomeres
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at least in budding yeast, is bound by RPA [24], we did
not robustly detect RPA70 or RPA34 at human telo-
meres by ChIP (data not shown). Furthermore, when
we used different anti-RAD17 antibodies in ChIP assays,
we found them to generate a relatively weak telomere
signal (data not shown), suggesting either that RAD17
is not localized to telomeres or that it associates with
them in a transient, and therefore hard-to-detect, man-
ner. Consistent with the latter possibility, knockdown
of RAD17 expression resulted in reduced telomerase ac-
tivity, suggesting that it may be required for 911 loading
at telomeres. Nevertheless, binding of 911 to telomeres
also might involve distinct mechanisms relative to how it
associates with sites of DNA damage and could require
interactions with other telomeric DNA binding factors,
although we did not detect coimmunoprecipitation of
911 with TRF1, TRF2, or hPot1 (data not shown).
Our findings, together with a recent report that Rad9
inactivation is associated with telomere loss and chro-
mosomal fusions [25], indicate that mammalian 911 reg-
ulates telomeres. This appears to be an evolutionarily
conserved function for 911, because orthologs of this
complex in Schizosaccharomyces pombe have been
reported to associate with telomeric repeats and to be
required for telomere-length maintenance [26]. Further-
more, progressive telomere shortening has been ob-
served in Caenorhabditis elegans lacking HUS-1 [27]
or MRT-2, a worm ortholog of Rad1 [28]. Interestingly,
mutation of mrt-2 is epistatic with telomerase inactiva-
tion [29], a genetic observation that is also in line with
our biochemical results of 911 interaction with telome-
rase in human cell extracts. Notably, the 911 complex
was previously shown to interact with and stimulate
other DNA polymerases involved in DNA lesion bypass
and DNA repair [6, 30, 31], suggesting that 911 may
have the more general ability to facilitate the activity of
atypical DNA polymerases dealing with discontinuous
DNA templates.
911 is the first DDR factor reported to associate with
telomerase. Other components of the same DNA-dam-
age-signaling pathway such as RPA70, RPA34, and
ATR were not observed to coimmunoprecipitate with
telomerase activity. This intriguing observation suggests
that 911, although integrated in a DNA-damage-signal-
ing pathway, also has a unique and independent role
in telomere maintenance. The observation that in vitro
telomerase activity is impaired in the absence of 911
suggests that telomere shortening in Hus1-deficient
cells could be the result of inefficient maintenance of
telomeres by telomerase. Notably, the rate of telomere
shortening that we observed in Hus1 null cells is higher
than that reported for mice lacking TERC, the RNA com-
ponent of telomerase, suggesting that additional mech-
anisms of telomere shortening might be at play in the ab-
sence of Hus1. It is worth considering that the presence
of a poorly processive telomerase on DNA could be
more detrimental to telomere stability than not having
telomerase at all: a poorly processive polymerase on
DNA can cause DNA replication fork stalling, which
can lead to fork reversal and hyperrecombination [32].
Therefore, it is possible that in cells lacking Hus1, a cru-
cial component of the S-phase checkpoint mechanism,
a poorly processive telomerase complex leads togeneration of aberrant DNA structures that can result in
the rapid loss of telomeric repeats through recombina-
tion [33]. Indeed, both Hus1 [34] and Rad9 [25] function
in homologous recombinational repair, and defects in
this process may further promote telomere instability.
Thus, telomere shortening in Hus1-deficient cells may
be the consequence of a combination of inefficient
telomerase activity and DNA-damage-response defi-
ciencies.
Supplemental Data
Supplemental Data include seven figures and Supplemental Exper-
imental Procedures and can be found with this article online at http://
www.current-biology.com/cgi/content/full/16/15/1551/DC1/.
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